These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23891615)

  • 1. Therapeutic and preventive effects of methylene blue on Alzheimer's disease pathology in a transgenic mouse model.
    Paban V; Manrique C; Filali M; Maunoir-Regimbal S; Fauvelle F; Alescio-Lautier B
    Neuropharmacology; 2014 Jan; 76 Pt A():68-79. PubMed ID: 23891615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
    McClean PL; Hölscher C
    Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged AβPP/PS1 double transgenic mice.
    Song Y; Cui T; Xie N; Zhang X; Qian Z; Liu J
    Int Immunopharmacol; 2014 May; 20(1):276-81. PubMed ID: 24667368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of lignan-riched extract of Shisandra chinensis on amyloid-β-induced cognitive impairment and neurotoxicity in the cortex and hippocampus of mouse.
    Jeong EJ; Lee HK; Lee KY; Jeon BJ; Kim DH; Park JH; Song JH; Huh J; Lee JH; Sung SH
    J Ethnopharmacol; 2013 Mar; 146(1):347-54. PubMed ID: 23333311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.
    Giuliani D; Ottani A; Zaffe D; Galantucci M; Strinati F; Lodi R; Guarini S
    Neurobiol Learn Mem; 2013 Sep; 104():82-91. PubMed ID: 23726868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tauroursodeoxycholic acid suppresses amyloid β-induced synaptic toxicity in vitro and in APP/PS1 mice.
    Ramalho RM; Nunes AF; Dias RB; Amaral JD; Lo AC; D'Hooge R; Sebastião AM; Rodrigues CM
    Neurobiol Aging; 2013 Feb; 34(2):551-61. PubMed ID: 22621777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Intranasal Formulation of Erythropoietin (Neuro-EPO) Prevents Memory Deficits and Amyloid Toxicity in the APPSwe Transgenic Mouse Model of Alzheimer's Disease.
    Rodríguez Cruz Y; Strehaiano M; Rodríguez Obaya T; García Rodríguez JC; Maurice T
    J Alzheimers Dis; 2017; 55(1):231-248. PubMed ID: 27662300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice.
    Mori T; Koyama N; Segawa T; Maeda M; Maruyama N; Kinoshita N; Hou H; Tan J; Town T
    J Biol Chem; 2014 Oct; 289(44):30303-30317. PubMed ID: 25157105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of long-term treatment with metrifonate, a cholinesterase inhibitor, on cholinergic activity, amyloid pathology, and cognitive function in APP and PS1 doubly transgenic mice.
    Liu L; Ikonen S; Heikkinen T; Tapiola T; van Groen T; Tanila H
    Exp Neurol; 2002 Feb; 173(2):196-204. PubMed ID: 11822883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylene blue improves streptozotocin-induced memory deficit by restoring mitochondrial function in rats.
    Li L; Qin L; Lu HL; Li PJ; Song YJ; Yang RL
    Brain Res; 2017 Feb; 1657():208-214. PubMed ID: 28034723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of quetiapine in a transgenic mouse model of Alzheimer's disease.
    He J; Luo H; Yan B; Yu Y; Wang H; Wei Z; Zhang Y; Xu H; Tempier A; Li X; Li XM
    Neurobiol Aging; 2009 Aug; 30(8):1205-16. PubMed ID: 18079026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temsirolimus promotes autophagic clearance of amyloid-β and provides protective effects in cellular and animal models of Alzheimer's disease.
    Jiang T; Yu JT; Zhu XC; Tan MS; Wang HF; Cao L; Zhang QQ; Shi JQ; Gao L; Qin H; Zhang YD; Tan L
    Pharmacol Res; 2014 Mar; 81():54-63. PubMed ID: 24602800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha7 nicotinic receptor agonist 4OH-GTS-21 protects axotomized septohippocampal cholinergic neurons in wild type but not amyloid-overexpressing transgenic mice.
    Ren K; King MA; Liu J; Siemann J; Altman M; Meyers C; Hughes JA; Meyer EM
    Neuroscience; 2007 Aug; 148(1):230-7. PubMed ID: 17640819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
    Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
    J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production.
    Arendash GW; Schleif W; Rezai-Zadeh K; Jackson EK; Zacharia LC; Cracchiolo JR; Shippy D; Tan J
    Neuroscience; 2006 Nov; 142(4):941-52. PubMed ID: 16938404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of methylene blue in Alzheimer's disease via mitochondria and cytochrome c oxidase.
    Atamna H; Kumar R
    J Alzheimers Dis; 2010; 20 Suppl 2():S439-52. PubMed ID: 20463399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naphthoquinone-tyrptophan reduces neurotoxic Aβ*56 levels and improves cognition in Alzheimer's disease animal model.
    Scherzer-Attali R; Farfara D; Cooper I; Levin A; Ben-Romano T; Trudler D; Vientrov M; Shaltiel-Karyo R; Shalev DE; Segev-Amzaleg N; Gazit E; Segal D; Frenkel D
    Neurobiol Dis; 2012 Jun; 46(3):663-72. PubMed ID: 22449754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subchronic memantine administration on spatial learning, exploratory activity, and nest-building in an APP/PS1 mouse model of Alzheimer's disease.
    Filali M; Lalonde R; Rivest S
    Neuropharmacology; 2011 May; 60(6):930-6. PubMed ID: 21281652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.